Imperial Oil Limited Common Stock vs Nuwellis Inc — how do they compare? Imperial Oil Limited Common Stock trades at $129.58 (market cap $62.87B), while Nuwellis Inc trades at $0.56 (market cap $1.68M). The key difference: Imperial Oil Limited Common Stock is far larger — about 37422.6× Nuwellis Inc's market cap, and Imperial Oil Limited Common Stock pays a 1.89% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| IMO | NUWE | |
|---|---|---|
Market Cap | $62.87B | $1.68M |
Volume | 507,550 | 375,944 |
Sector | Energy | Health |
52-Week High | $138.33 | $146.65 |
52-Week Low | $83.72 | $0.53 |
Enterprise Value | $63.78B | -$2.03M |
Dividend Yield | 1.89% | — |
Typical Hold Time | — | 27 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NUWE trades at $0.621, down 7.35% today, with a bearish technical signal despite oversold RSI readings. The company shows revenue growth with 2026 revenue reaching $9M, but continues to post significant losses with a -125.63% net income margin. Recent positive developments include strong Aquadex console adoption and expanded pediatric footprint, though cash flow remains negative requiring ongoing financing.
The outlook remains challenging with persistent losses and negative cash flow offset by promising commercial momentum. Investment opportunity hinges on the company's ability to achieve profitability while risks include execution challenges and dependence on financing. Analyst sentiment is mixed with equal buy/hold ratings reflecting the high-risk, high-reward nature of this medical technology stock.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Imperial Oil Limited is a Canadian integrated energy company that explores for and produces crude oil and natural gas, operates oil sands projects at Cold Lake, Kearl, and Syncrude, and refines and markets petroleum products under the Esso and Mobil brands. ExxonMobil Corporation holds a majority ownership stake in the company.
Read more on IMO →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →